The 2028 International Congress of the International Society of Blood Transfusion (ISBT 2028) will be held in Yokohama, Japan, 4-8 June, 2028. Organised collaboratively by ISBT and The Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT), the event returns to Japan after 19 years, following three previous international (1960, 1996) and regional congresses (2009) held in the country.
Working in partnership with the City of Yokohama and the Japan National Tourism Organisation (JNTO), the Yokohama City Visitors Bureau (YCVB) and venue PACIFICO Yokohama supported JSTMCT’s successful bid to host ISBT 2028.
Professor Masahiro Satake (pictured), ISBT2028 chair (senior counsellor, Japanese Red Cross Society) said he was delighted that Yokohama had been selected to host ISBT 2028. “With its excellent domestic and international access and exceptional infrastructure for hosting international conferences, I am confident that participants will find their stay in Yokohama highly rewarding.
The ISBT is widely recognised as the leading authority in transfusion medicine, dedicated to promoting advancements in transfusion science and elevating global standards of practice. With the collaboration and support of all stakeholders, I am committed to ensuring that ISBT 2028 will be a productive and impactful event.”
PACIFICO Yokohama said it expected the Yokohama congress to draw 4,500 on-site participants (including approximately 3,500 from outside Japan). Organiser ISBT said the conference programme would bridge the local community, holding blood transfusion-related events for local citizens alongside the congress.
